Building Biotechnology Booksigning Today at BIO

I will be signing the following books today at the BIO bookstore from 3pm to 4:30pm: Building Biotechnology: The definitive biotechnology industry primer Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property Best Practices in Biotechnology Education 22 International Best Practices in K-12, College, Certificate, Master’s, Doctoral, […]


Profiling Cuban Biotechnology

I will be giving a brief talk on the Cuban Biotechnology industry during a panel at the Biotechnology Industry Organization conference today. What: Cuban Biotechnology: An Overview of Cuba’s Drug and Vaccine Developments and Innovations When: 2:00 – 2:45pm Where: Room 145B Who: Elaine Scheye, Yali Friedman, Halla Thortsteinsdottir, Pedro Freyre I will be largely […]


Building the Case for Biotechnology Booksigning Today at BIO

Mark Ahn, Michael Alvarez, and Anne York, the editors of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business will be signing books today at the BIO 2011 Convention in Washington DC from 3:00-4:30 pm in the BIO bookstore.  


Biotechnology Book Booksignings at BIO 2011

The following Logos Press authors will be signing books at the BIO 2011 Convention in Washington DC Monday June 27th 3:00-4:30pm Mark Ahn, Michael Alvarez, Anne York Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business Tuesday June 28th 3pm-4:30pm Yali Friedman Building Biotechnology: The definitive biotechnology industry primer […]


Individual Biotechnology Management Cases now Available

I am pleased to announce the availability of  individual cases from Building the Case for Biotechnology Management Case Studies in Science, Laws, Regulations, Politics, and Business in digital and printed formats. The casebook, which was recently reviewed in Nature Biotechnology, features 22 case studies in science; law, regulation, politics; and business, and a foreword by […]


Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011 *Drugs may be covered by multiple patents  Tradename Applicant Generic Name Patent Number Patent Expiration FEMARA Novartis Pharms letrozole 4,978,672 Jun 3, 2011 TAZORAC Allergan tazarotene 5,089,509 Jun 13, 2011 AVAGE Allergan tazarotene 5,089,509 Jun 13, 2011 NUEDEXTA Avanir Pharms dextromethorphan hydrobromide; quinidine sulfate 5,166,207 Jun 17, 2011 […]


Neglected Disease Drug Development: Incentives for Success

This paper is a final project from the NIH Foundation for Advanced Education in the Sciences TECH 366, a course in Biotechnology Management Neglected Disease Drug Development: Incentives for Success Dr. Jason Chong How are treatments being developed for neglected diseases? Historically, pharmaceutical research and development (R&D) of drugs have been driven by the private […]


Do NOT follow this link or you will be banned from the site!